While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated
Now in the grip of a third wave of infections, South Africa is inoculating its population with Johnson & Johnson and Pfizer vaccines, but the rollout has been slow partly due to setbacks in supply.
"Swissmedic has carefully examined the indication-extension application submitted by Pfizer," the regulator said in a statement, after giving the shot temporary ordinary authorisation for 12- to 15-year-olds.
Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 million doses of the Pfizer vaccine.
Sri Lanka is the first country in South Asia to approve the Pfizer vaccine. It has also approved Russia's Sputnik and China's Sinopharm vaccines for emergency use.
"Swissmedic will review the application in the rolling procedure. Pfizer can submit the latest data continuously without having to wait for the conclusive results from the clinical studies," the watchdog said on its website.
The vaccines from the US drug maker and its German partner BioNTech will be delivered over the period 2021-2023, Commission President Ursula von der Leyen said at a briefing.
The agreement would be enough to inoculate the 450 million EU population for two years and comes as the bloc seeks to shore up long-term supplies.
"We were surprised, and very pleased," Moss told reporters at a briefing about the findings. "But, of course, this does go with the excellent clinical protection that we're seeing with the vaccine - so it does correlate."
Pfizer and its co-developer BioNTech said earlier on Thursday that updated clinical trial data showed their vaccine is around 91% effective at preventing COVID-19 cases.
"COVID-19 vaccine supplies for Vietnam have been impacted by the complicated developments of the coronavirus pandemic in the world," the government said in a statement.
Vietnam's vaccination campaign, which was launched on March 8, has relied solely on the batch of 117,600 doses of the AstraZeneca vaccine it received last month.
The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial.
Pfizer was the first company to apply for emergency use authorisation in India, proposing to import doses from its US and European facilities instead of producing locally.
The doses to vaccinate two million people will be supplied in addition to the planned deliveries, to ease border movement and to tackle virus hotspots, the Commission said.
"To tackle aggressive variants of the virus and to improve the situation in hotspots, quick and decisive action is necessary," the president of the Commission, Ursula von der Leyen, said.
Speaking in Brasilia, Guedes said President Jair Bolsonaro had spoken with the global head of Pfizer and was scheduled to speak with the head of Janssen, the pharmaceutical subsidiary of Johnson & Johnson.
The government last week said it intended to buy 100 million doses from Pfizer and 38 million from Janssen through the end of December.
The Pfizer/BioNTech shot is the first vaccine against the novel coronavirus to receive full approval in Brazil, Anvisa said. Other vaccines developed by AstraZeneca and China's Sinovac Biotech Ltd, have only been approved for emergency use so far.
The approval is good news for a country whose immunization campaign has been plagued by delays and political squabbling.
The advisory committee held its regular weekly meeting on Thursday and discussed the laboratory study, which was published in the New England Journal of Medicine this week.
South Africa is counting on the Pfizer shot, developed with German partner BioNTech, to step up its vaccination programme after administering its first Johnson & Johnson doses on Wednesday.
Today we remember all the victims of COVID-19, the more than 57,000 irreplaceable Colombians who have left a void and who we will honor fighting the virus with a vaccine.
This afternoon the first shipment of vaccines from the pharmaceutical company Pfizer with the first 50,000 vaccines will arrive in our country from Belgium.
Japan's vaccine chief said last week that export controls imposed by the European Union, where some vaccines are made, could delay the Asian nation's inoculation effort.
Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.
The Pfizer vaccine is produced in Belgium and the European Commission said on Friday it had agreed a plan to control exports of vaccines from the European Union, including to Britain.
With the assurances of both the EU and Belgian Ambassadors, the COVID-19 immunisation plan is expected to proceed according to plan.